Vc2vc is meeting that invites investors that previously have not been investing in the life sciences or in the Nordic countries. By presenting the Nordic companies through the investors we hope to get an easier way for other investors to see the business proposition, an investment would mean. In this vc2vc partnering meeting we embrace the broad meaning of life science to include everything from digital health and medical technology to pharmaceuticals.
Bionordic provides online registration and partnering platform.
Presenting an impressive line-up of participants addressing evidence and research as well as development and promotion, the 2017 edition of the Biovision life sciences forum affirms its status as a standout gathering of knowledge among other such international meetings. This year, the forum will welcome major players from the health sector representing each step of the value chain (research, innovation, partnerships and finance) with the goal of arriving at concrete solutions to existing and future health issues.
Bionordic provides online registration, payment, projects’ submission and partnering platform.
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 145 affiliates and a total of around 47,500 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.
Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative “Making more Health” and caring for the employees. Respect, equal opportunities and reconciling career and family form the foundation of the mutual cooperation. In everything it does, the company focuses on environmental protection and sustainability.
In 2016, Bionordic organized the Boehringer Ingelheim Partnering Day in Stockholm.
SwedenBIO is the national non-profit association for the life science industry in Sweden, with nearly 200 members. Sweden has an innovative life science industry, strong academia and world leading infrastructure for research.
SwedenBIO members are companies active within pharma, biotech, diagnostics and medtech and comprise the entire range from small start-ups, to SMEs and large enterprises. Many are engaged in research and development. Other members are experts in fields such as IP, law, finance, product development, life science communication and business development.
Since 2013, Bionordic organizes the Nordic Life Science Days, a SwedenBIO event.